Commercially Available Injectables in Diabetes – Insulin, Incretins, and More
The management of type 2 diabetes (T2D) has evolved significantly with the emergence of diverse medication classes, including metformin, sulfonylureas, dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, sodium/glucose cotransporter 2 inhibitors, thiazolidinediones,...
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Wolters Kluwer Medknow Publications
2023-04-01
|
| Colección: | International Journal of Diabetes and Technology |
| Materias: | |
| Acceso en línea: | https://journals.lww.com/10.4103/ijdt.ijdt_29_23 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|